Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis
- PMID: 17901837
- DOI: 10.1097/01.CCM.0000288102.15975.BA
Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis
Abstract
Objective: Electrical vagus nerve stimulation inhibits proinflammatory cytokine production and prevents shock during lethal systemic inflammation through an alpha7 nicotinic acetylcholine receptor (alpha7nAChR)-dependent pathway to the spleen, termed the cholinergic anti-inflammatory pathway. Pharmacologic alpha7nAChR agonists inhibit production of the critical proinflammatory mediator high mobility group box 1 (HMGB1) and rescue mice from lethal polymicrobial sepsis. Here we developed a method of transcutaneous mechanical vagus nerve stimulation and then investigated whether this therapy can protect mice against sepsis lethality.
Design: Prospective, randomized study.
Setting: Institute-based research laboratory.
Subjects: Male BALB/c mice.
Interventions: Mice received lipopolysaccharide to induce lethal endotoxemia or underwent cecal ligation and puncture to induce polymicrobial sepsis. Mice were then randomized to receive electrical, transcutaneous, or sham vagus nerve stimulation and were followed for survival or euthanized at predetermined time points for cytokine analysis.
Measurements and main results: Transcutaneous vagus nerve stimulation dose-dependently reduced systemic tumor necrosis factor levels during lethal endotoxemia. Treatment with transcutaneous vagus nerve stimulation inhibited HMGB1 levels and improved survival in mice with polymicrobial sepsis, even when administered 24 hrs after the onset of disease.
Conclusions: Transcutaneous vagus nerve stimulation is an efficacious treatment for mice with lethal endotoxemia or polymicrobial sepsis.
Comment in
-
Assessment of vagal activity during transcutaneous vagus nerve stimulation in mice.Crit Care Med. 2008 Jun;36(6):1990. doi: 10.1097/CCM.0b013e31817c3b6a. Crit Care Med. 2008. PMID: 18520671 No abstract available.
Comment on
-
Mechanical vagus nerve stimulation--A new adjunct in sepsis prophylaxis and treatment?Crit Care Med. 2007 Dec;35(12):2868-9. doi: 10.1097/01.CCM.0000288083.32202.DC. Crit Care Med. 2007. PMID: 18043211 No abstract available.
Similar articles
-
Selective alpha7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis.Crit Care Med. 2007 Apr;35(4):1139-44. doi: 10.1097/01.CCM.0000259381.56526.96. Crit Care Med. 2007. PMID: 17334244
-
Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis.J Exp Med. 2006 Jul 10;203(7):1623-8. doi: 10.1084/jem.20052362. Epub 2006 Jun 19. J Exp Med. 2006. PMID: 16785311 Free PMC article.
-
Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis.Nat Med. 2004 Nov;10(11):1216-21. doi: 10.1038/nm1124. Epub 2004 Oct 24. Nat Med. 2004. PMID: 15502843
-
The role of high mobility group box-1 protein in severe sepsis.Curr Opin Infect Dis. 2006 Jun;19(3):231-6. doi: 10.1097/01.qco.0000224816.96986.67. Curr Opin Infect Dis. 2006. PMID: 16645483 Review.
-
The vagus nerve and the inflammatory reflex: wandering on a new treatment paradigm for systemic inflammation and sepsis.Surg Infect (Larchmt). 2012 Aug;13(4):187-93. doi: 10.1089/sur.2012.126. Epub 2012 Aug 22. Surg Infect (Larchmt). 2012. PMID: 22913335 Review.
Cited by
-
Ultrasound stimulation of the vagus nerve as a treatment modality for anxiety.Front Psychiatry. 2024 Oct 2;15:1376140. doi: 10.3389/fpsyt.2024.1376140. eCollection 2024. Front Psychiatry. 2024. PMID: 39415887 Free PMC article. Review.
-
Impact of sympathetic hyperactivity induced by brain microglial activation on organ damage in sepsis with chronic kidney disease.J Intensive Care. 2024 Sep 2;12(1):31. doi: 10.1186/s40560-024-00742-2. J Intensive Care. 2024. PMID: 39223624 Free PMC article.
-
Neuroimmune Interactions in the Gut and Their Significance for Intestinal Immunity.Cells. 2019 Jul 2;8(7):670. doi: 10.3390/cells8070670. Cells. 2019. PMID: 31269754 Free PMC article. Review.
-
HMGB1 is a therapeutic target for sterile inflammation and infection.Annu Rev Immunol. 2011;29:139-62. doi: 10.1146/annurev-immunol-030409-101323. Annu Rev Immunol. 2011. PMID: 21219181 Free PMC article. Review.
-
Modulation of TNF release by choline requires alpha7 subunit nicotinic acetylcholine receptor-mediated signaling.Mol Med. 2008 Sep-Oct;14(9-10):567-74. doi: 10.2119/2008-00079.Parrish. Mol Med. 2008. PMID: 18584048 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical